SOLARA.NS

Solara Active Pharma Sciences Limited SOLARA.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SOLARA.NS ALEMBICLTD.NS MOREPENLAB.BO MOREPENLAB.NS INDOCO.BO INDOCO.NS SMSPHARMA.BO SMSPHARMA.NS IOLCP.BO IOLCP.NS
6M 15.25 % -2.65 % -8.72 % -8.83 % 18.91 % 18.35 % 33.16 % 33.21 % 40.97 % 40.57 %
YTD -14.44 % -22.58 % -37.96 % -37.93 % -13.26 % -13.37 % 12.11 % 12.63 % 15.83 % 15.63 %
1Y -27.03 % -19.49 % -40.11 % -40.11 % -13.79 % -13.85 % -6.45 % -6.38 % 17.18 % 16.95 %
3Y 57.71 % 52.73 % 82.45 % 82.71 % -14.43 % -14.56 % 224.87 % 227.04 % 34.22 % 33.24 %
5Y -43.39 % 5.95 % 89.48 % 89.40 % 14.77 % 13.80 % 221.44 % 221.04 % -29.69 % -29.89 %
10Y 158.64 % 175.70 % 188.39 % 188.27 % -15.30 % -15.28 % 271.76 % 271.74 % 493.34 % 492.47 %
From the beginning 158.64 % 2 451.24 % -67.22 % 141.17 % 445.36 % 447.46 % 757.69 % 753.81 % 10 065.25 % 758.75 %

Dividend

Solara Active Pharma Sciences Limited

Alembic Limited

Morepen Laboratories Limited

Morepen Laboratories Limited

Indoco Remedies Limited

Indoco Remedies Limited

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited